These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

125 related articles for article (PubMed ID: 4737674)

  • 21. [Cholera enterotoxin--its biological activity and mechnism of action].
    Oashi M
    Nihon Saikingaku Zasshi; 1974 Mar; 29(2):354-67. PubMed ID: 4368074
    [No Abstract]   [Full Text] [Related]  

  • 22. Evidence that a non-O1 Vibrio cholerae produces enterotoxin that is similar but not identical to cholera enterotoxin.
    Yamamoto K; Takeda Y; Miwatani T; Craig JP
    Infect Immun; 1983 Sep; 41(3):896-901. PubMed ID: 6411622
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Comparative study of Clostridium difficile toxin A and cholera toxin in rabbit ileum.
    Triadafilopoulos G; Pothoulakis C; Weiss R; Giampaolo C; Lamont JT
    Gastroenterology; 1989 Nov; 97(5):1186-92. PubMed ID: 2551764
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Cholera enterotoxin-induced mucus secretion and increase in the mucus blanket of the rabbit ileum in vivo.
    Leitch GJ
    Infect Immun; 1988 Nov; 56(11):2871-5. PubMed ID: 3169991
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Pathogenesis of experimental cholera. Preparation and isolation of choleragen and choleragenoid.
    Finkelstein RA; LoSpalluto JJ
    J Exp Med; 1969 Jul; 130(1):185-202. PubMed ID: 4978880
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Biological similarity of enterotoxins of Vibrio cholerae serotypes other than type 1 to cholera toxin and Escherichia coli heat-labile enterotoxin.
    Lahiri A; Agarwal RK; Sanyal SC
    J Med Microbiol; 1982 Nov; 15(4):429-40. PubMed ID: 6757437
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Effects of prostaglandins and cholera enterotoxin on intestinal mucosal cyclic AMP accumulation. Evidence against an essential role for prostaglandins in the action of toxin.
    Kimberg DV; Field M; Gershon E; Henderson A
    J Clin Invest; 1974 Mar; 53(3):941-9. PubMed ID: 4359941
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Simplified method for purification of Clostridium perfringens type A enterotoxin.
    Sakaguchi G; Uemura T; Riemann HP
    Appl Microbiol; 1973 Nov; 26(5):762-7. PubMed ID: 4357653
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Improved methods for purification of an enterotoxin produced by Bacillus cereus.
    Shinagawa K; Sugiyama J; Terada T; Matsusaka N; Sugii S
    FEMS Microbiol Lett; 1991 May; 64(1):1-5. PubMed ID: 1906824
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Evidence for production of an enterotoxin and cholera toxin cross-reactive factor by Aeromonas hydrophila.
    Chopra AK; Houston CW; Genaux CT; Dixon JD; Kurosky A
    J Clin Microbiol; 1986 Oct; 24(4):661-4. PubMed ID: 3771756
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Isolation of the thermolabile E. coli enterotoxin and the study of its biological properties].
    Volunskiĭ MIa; Vartanian IuP; Stanislavskiĭ ES; Tabachnik AL; Girshovich ES
    Biull Eksp Biol Med; 1976 Oct; 82(10):1237-9. PubMed ID: 800957
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Immunogenicity and antigenic relationship of Salmonella enterotoxin with other enterotoxins.
    Rahman H; Sharma VD
    Zentralbl Bakteriol; 1995 Oct; 282(4):416-26. PubMed ID: 9810665
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Experimental studies on cholera immunization. II. Evidence for protective antitoxic immunity mediated by serum antibodies as well as local antibodies.
    Holmgren J; Andersson A; Wallerstrom G; Ouchterlony O
    Infect Immun; 1972 May; 5(5):662-7. PubMed ID: 4637602
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Cholera-like enterotoxin in certain Campylobacter jejuni strains: some observations.
    Hariharan H; Panigrahi D
    Microbiologica; 1990 Jan; 13(1):7-9. PubMed ID: 2308530
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Hemagglutinating and hydrophobic surface properties of salmonellae producing enterotoxin neutralized by cholera anti-toxin.
    Jiwa SF; Månsson I
    Vet Microbiol; 1983 Oct; 8(5):443-58. PubMed ID: 6649404
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Purification and properties of permeability factor-cholera enterotoxin from complex and synthetic media.
    Richardson SH; Noftle KA
    J Infect Dis; 1970 May; 121():Suppl 121:73+. PubMed ID: 4987012
    [No Abstract]   [Full Text] [Related]  

  • 37. [Vibrio eltor strain, serotype Ogawa, the producer of cholera enterotoxin].
    Saiamov RM; Avrorov VP; Khanum'ian TA
    Zh Mikrobiol Epidemiol Immunobiol; 1983 Mar; (3):40-2. PubMed ID: 6342310
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Cholera].
    Chevrel B
    Presse Med (1893); 1970 Apr; 78(18):840. PubMed ID: 5441646
    [No Abstract]   [Full Text] [Related]  

  • 39. Entero-cytolysin (EC) from Vibrio cholerae non-O1 (some properties and pore-forming activity).
    Zitzer AO; Nakisbekov NO; Li AV; Semiotrochev VL; Kiseliov YuL ; Muratkhodjaev JN; Krasilnikov OV; Ezepchuk YuV
    Zentralbl Bakteriol; 1993 Nov; 279(4):494-504. PubMed ID: 7508299
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The effect of cholera toxin and heat labile and heat stable Escherichia coli enterotoxin on cyclic AMP concentrations in small intestinal mucosa of pig and rabbit.
    Hamilton DL; Johnson MR; Forsyth GW; Roe WE; Nielsen NO
    Can J Comp Med; 1978 Jul; 42(3):327-31. PubMed ID: 210913
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.